Statements of Shareholders' Deficiency - USD ($)	12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853
Beginning balance	$ (1,034,012)	$ (930,624)
Net Loss	$ (119,620)	(103,388)
Ending balance (in shares)	1,233,853
Ending balance	$ (1,153,632)	$ (1,034,012)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance (in shares)	1,233,853	1,233,853
Beginning balance	$ 1,233	$ 1,233
Ending balance (in shares)	1,233,853	1,233,853
Ending balance	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	81,323	81,323
Ending balance	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(1,116,568)	(1,013,180)
Net Loss	(119,620)	(103,388)
Ending balance	$ (1,236,188)	$ (1,116,568)